Australia’s Therapeutic Goods Administration (TGA) said it’s cracking down on advertisements for bioresonance devices and similar technology that don’t comply with its regulations.

The agency flagged bioresonance — a non-invasive therapy that uses electrodes for diagnosis and treatment — for a high rate of non-compliance in advertising and noted that it has been the focus of previous regulatory action.

The agency noted a list of false treatment claims seen in ads, including that bioresonance can help or treat cancers, joint pain, osteoarthritis and disorders like chronic fatigue and insomnia, among others.